On July 29, 2021, the Clozapine REMS program was modified to include changes to the authorization process for dispensing clozapine and changes to ANC reporting requirements. Starting November 15, 2021, pharmacists will no longer be able to use telecommunication verification (also known as the switch...
Additional ANC monitoring is required for any patient reporting onset of fever (temperature of 38.5°C or 101.3°F, or greater) during the 2 weeks after discontinuation [seeWARNINGS AND PRECAUTIONS]. Monitor all patients carefully for the recurrence of psychotic symptoms and symptoms related to chol...
When discontinuing clozapine, what is the necessary reporting step? Submit decision to Clozapine REMS by either signing into the website, calling their contact center, or faxing patient status form. You recently discontinued your patient's clozapine prescription and they're now presenting with a feve...
Clozapine REMS Program CLOZARIL is only available through a restricted program under a REMS called the Clozapine REMS Program because of the risk of severe neutropenia. Notable requirements of the Clozapine REMS Program include: Healthcare professionals who prescribe CLOZARIL must be certified with th...
Notable requirements of the Clozapine REMS Program include: Healthcare professionals who prescribe CLOZARIL must be certified with the program by enrolling and completing training Patients who receive CLOZARIL must be enrolled in the program and comply with the ANC testing and monitoring requirements ...